Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder.
Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder: A Randomized Controlled Trial
About this trial
This is an interventional treatment trial for Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder: A Randomized Controlled Trial
Eligibility Criteria
Inclusion Criteria:
Patient aged from 20 to 40 years age and taking anti-depressant drugs, were selected for study.
Exclusion Criteria:
Pregnant and lactating women and patients with history of allergy to omega-3 fatty acids shellfish were excluded.
Patients with Serious neurological and medical conditions that can likely to interfere with the treatment of depression such as dementia, schizophrenia, epilepsy were also excluded.
Sites / Locations
- Zaheer Ahmad
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Omega-3
Placebo
one capsule of omega-3 (EPA 300mg, and 200mg DHA) were given to treatment group along with already taking anti depressant drugs( citalopram, escitalopram, paroxetine 1 tablet at night time)
one capsule of 500 mg corn oil, along with already taking anti depressant drugs( citalopram, escitalopram, paroxetine 1 tablet at night time) were given to placebo group